Protara Therapeutics, Inc.
TARA$222M
Micro CapNASDAQBiological Products, (No Diagnostic Substances)🇺🇸North AmericaNEW YORK28 employees
Drugs in Pipeline
2
Phase 3 Programs
1
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
TARA News
Catalyst Timeline
0 upcoming, 1 past
No catalysts found.
Drug Pipeline
Choline Chloride for Injection
Choline Deficiency
TARA-002
Non-muscle Invasive Bladder Cancer
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Choline Chloride for Injection | Phase 3 | Choline Deficiency | - | - |
TARA-002 | Phase 2 | Non-muscle Invasive Bladder Cancer | - | - |
Regulatory Approvals
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply